BioSpace News Archive

Genetown

Thermo Fisher Scientific Adds Digital PCR to Genetic Analysis Capabilities

Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.

September 20, 2021
·
3 min read
Drug Development

Eiger BioPharmaceuticals Announces Interim Analysis and Continuation of Dosing of Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Outpatients

Eiger BioPharmaceuticals, Inc. today announced that the Data Safety Monitoring Board (DSMB) recommended that investigators continue enrollment of the Peginterferon Lambda arm in the Phase 3 TOGETHER platform study.

September 20, 2021
·
6 min read
Lone Star Bio

Bluegrass Vascular Announces Decision by Medicare to Assign a New Technology Ambulatory Payment Classification (APC) for the Surfacer® System Procedure

Bluegrass Vascular Technologies announced that the Centers for Medicare & Medicaid Services has finalized a new Healthcare Common Procedure Coding System code and New Technology Ambulatory Payment Classification assignment for use of the Surfacer® Inside-Out® Access Catheter System procedure.

September 20, 2021
·
4 min read
Business

Fore Biotherapeutics Continues to Build Leadership Team with Executive and Board Appointments

Fore Biotherapeutics today announced the appointment of Kim Blackwell, M.D., as a member of the Board of Directors and R&D/Science Chair, and Sujit Basu, Ph.D., as Senior Vice President of Manufacturing and Technical Operations.

September 20, 2021
·
5 min read
Biotech Bay

Imago BioSciences Announces Its Addition to the Russell 2000® Index

Imago BioSciences , Inc. today announced that it will be added to the Russell® 2000 Index as part of the planned second quarter IPO additions scheduled to join the Russell US Indexes on September 20, 2021.

September 20, 2021
·
3 min read
BioMidwest

Forge Biologics Announces Regulatory Updates from FDA and EMA, Accelerating Manufacturing and Clinical Trial Momentum

Forge Biologics today announced that it has received additional designations and regulatory feedback from the European Medicines Agency (EMA) and the U.S. Food & Drug Administration (FDA), advancing the manufacturing capabilities for its own and clients’ AAV gene therapies.

September 20, 2021
·
6 min read
BioMidwest

Aptinyx to Participate in 2021 Cantor Virtual Global Healthcare Conference

Aptinyx Inc. today announced that Norbert Riedel, Ph.D., chief executive officer, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on September 30, 2021 at 10:00 a.m. ET.

September 20, 2021
·
1 min read
Sales of Medical Ventilators to Increase by 9.9% CAGR through 2031

A Fact.MR survey on medical ventilators market offers detailed analysis on growth drivers and trends affecting demand in terms of product type, technology and end user.

September 20, 2021
·
8 min read
Flow Directed Catheter Market: Increase in Prevalence of Cardiovascular Diseases to Drive the Market

Flow directed catheters are designed so that the flow of blood through an artery directs the catheter tip along the arterial flow path and to the target site.

September 20, 2021
·
5 min read
Flow Diverters Market | Expansive Coverage on the Latest Developments in the Market

There is a rapid increase in the cases of brain aneurysms in different countries across the globe. The risk factors associated with these brain aneurysms are driving growth in the flow diverters market.

September 20, 2021
·
4 min read